Real-world evidence (RWE) and Health Economics and Outcomes Research (HEOR) are two key tools in informing stakeholders such as regulatory agencies, healthcare providers, patients and care givers, payers, and policymakers about the effectiveness, safety and value of a therapy.
Achieve Your Real-World Evidence Goals with EmpiricBio:
Curating the appropriate real-world data can be challenging. Moreover, it’s daunting designing an optimal study to generate the right evidence and gain valuable insights.
EmpiricBio RWE solutions is three dimensional-we work with your own data source or use EmpiricBio’s housed public data or our network of external source data lakes with partner organizations. What is ideal for your business and evidence needs is key.
- Real-World Evidence (RWE) studies rely on various databases to capture real-world data (RWD). These databases include:
- Claims Databases
- Electronic Health Records (EHRs) Databases
- Disease and Registry Databases
- Hospital and Integrated Health System Database
- Biobank and Genomic Databases
- Real-World Evidence (RWE) plays a crucial role in life sciences by providing insights into the effectiveness, safety, and value of medical interventions in real-world settings. Key uses of RWE in life sciences include:
- Drug Development & Regulatory Decision-Making
- Market Access & Health Economics
- Pharmacovigilance & Drug Safety
- Precision Medicine & Personalized Treatment
- Clinical Trial Optimization
- Competitive Intelligence & Commercial Strategy
- Epidemiology & Medical Affairs